Phreesia, Inc.
Phreesia, Inc. is listed today as Phreesia, Inc.: market value, financials and filings are on its company page.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2017 | $34 M | No. 3 | $10 to $50 million | equity | SEC | |
| Oct 2014 | $30 M | No. 2 | $10 to $50 million | equity, options | SEC | |
| Apr 2010 | $20 M | No. 1 | $10 to $50 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Phreesia, Inc., its revenue in fiscal 2026 came from these product and service lines: Subscription and related services $219.46 million (46%), Network solutions $139.67 million (29%), Payment solutions $121.46 million (25%).
Annual report (SEC XBRL) · Jan 2026
Phreesia, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2017).
SEC Form D · Dec 2017
The industry group it chose in its notices: Other Health Care.
SEC Form D · Dec 2017
Products and services#
No products or services of Phreesia, Inc. are on record.
Investors#
13 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Ascension Health Ventures II, LLC | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| CHV II, L.P. | Fund or asset manager | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| HLM Venture Associates II, LLC | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| HLM Venture Partners II, L.P. | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| LLR Capital IV, LLC | Fund or asset manager | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| LLR Capital IV, L.P. | Fund or asset manager | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| LLR Equity Partners IV, L.P. | Private equity | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| LLR Equity Partners Parallel IV, L.P. | Private equity | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Polaris Venture Management Co. V, L.L.C. | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Polaris Venture Partners Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Polaris Venture Partners Special Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Polaris Venture Partners V, L.P. | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 10 investors.
Largest shareholders today
Institutions holding Phreesia, Inc. shares, as of Sep 30, 2026.
- Pale Fire Capital SE$92 M14.38%
- BlackRock, Inc.$74 M11.49%
- Vanguard Portfolio Management LLC$34 M5.28%
- AQR Capital Management LLC$28 M4.30%
- Vanguard Capital Management LLC$25 M3.98%
- T. Rowe Price Investment Management, Inc.$19 M2.91%
- State Street Corp$16 M2.55%
- Acadian Asset Management LLC$15 M2.35%
- Algert Global LLC$14 M2.22%
- Jacobs Levy Equity Management, Inc$13 M2.01%
- Geode Capital Management, LLC$12 M1.83%
- Qube Research & Technologies Ltd$11 M1.75%
- Morgan Stanley$11 M1.74%
- Goldman Sachs Group Inc$11 M1.67%
- Nuveen, LLC$10 M1.63%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Chaim Indig | Executive officer | Dec 2017 |
| Charles Kallenbach | Executive officer | Dec 2017 |
| Thomas Altier | Executive officer | Dec 2017 |
| Evan Roberts | Executive officer | Oct 2014 |
| Rory Parness | Executive officer | Aug 2010 |
| Alan Spoon | Director | Dec 2017 |
| Chaim Indig | Director | Dec 2017 |
| Dusty Lieb | Director | Dec 2017 |
| Edward Cahill | Director | Dec 2017 |
| Michael Weintraub | Director | Dec 2017 |
| Scott Perricelli | Director | Dec 2017 |
| Victor Kats | Director | Dec 2017 |
| William Conroy | Director | Nov 2017 |
| Matthew Downs | Director | Aug 2010 |
About
American healthcare software company.
Went public since 2019. Its SEC number is that of a company listed on a stock exchange.